Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials

J.L. Perez-Gracia*, N. Penel, E. Calvo, A. Awada, H.T. Arkenau, T. Amaral, V. Grünwald, M.F. Sanmamed, L. Castelo-Branco, G. Bodoky, M.P. Lolkema, M. Di Nicola, P. Casali, R. Giuliani, G. Pentheroudakis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: During recent years, the burden of bureaucracy in clinical research has increased dramatically, adversely
impacting the activity of investigators and clinical research teams. Although compliance with the Declaration of Helsinki,
the guidelines for Good Clinical Practice (GCP), and other applicable regulations remains unquestionable, their
overinterpretation and substitution by the internal operating procedures of sponsors and Contract Research
Organizations (CROs) have increased the administrative burden. A survey conducted by the European Society for
Medical Oncology (ESMO) Clinical Research Observatory (ECRO) among 940 investigators confirmed that they
considered that the administrative burden in clinical research is excessive; that administrative procedures could be
reduced without affecting the safety and the rights of the patients and the quality of the data; and that
bureaucracy represents an obstacle for clinical research.
Methods: A panel of physicians with extensive experience in clinical research, composed by members of the ECRO and
the ESMO Scientific Medical and Public Policy divisions, analyzed clinical trial procedures related to administrative
workflow, pharmacovigilance, and medical care.
Results: The panel identified situations that generate debate between investigators and sponsors/CROs and selected
real clinical scenarios that exemplify such situations. The panel discussed and proposed specific recommendations
for those situations, based on GCP.
Conclusions: This initiative aspires to streamline clinical research procedures and to become a platform for discussion
among all clinical trial stakeholders, with the aim of promoting the sustainability of clinical research and the care of
cancer patients
Original languageEnglish
Pages (from-to)70-77
Number of pages8
JournalAnnals of Oncology
Volume34
Issue number1
Early online date6 Oct 2022
DOIs
Publication statusPublished - Jan 2023

Bibliographical note

Funding Information:
The panel acknowledges the work of Klizia Marinoni and Delanie Young, from the Scientific and Medical Division at ESMO, for coordinating the project and for editorial assistance, and Paul Miller, PhD, from University of Navarra, for English language editing.

Publisher Copyright:
© 2022 European Society for Medical Oncology

Fingerprint

Dive into the research topics of 'Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials'. Together they form a unique fingerprint.

Cite this